MetaCap

Baird Medical Investment Holdings Ltd (BDMD)

NASDAQ: BDMDHealth CareMedical/Dental InstrumentsUSD

0.0897-0.0133 (-12.91%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BDMD stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$0.55
52-week range
0.073 – 3.70
Day range
0.086 – 0.0988
Volume / Avg
1.60M / 16.31M
Beta
—

52-week range

$0.073$3.70

BDMD stock today

On Nov 20, BDMD ended the session at $0.0897, shedding $0.0133 (12.91%), versus the S&P 500's 3.70% decline. Trading was light, with 1.60M shares changing hands, about 10% of the average daily volume. Shares are 97.6% below their 52-week high of $3.70, set on Mar 2, 2026 and 22.9% above the 52-week low of $0.073, near the bottom of the past year's range.

BDMD is down 93.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 93.6%. Baird Medical Investment has posted a net loss over the last twelve months (EPS of -$0.55), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Baird Medical Investment

Company profile

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors.

Industry
Medical/Dental Instruments
CEO
Ms. Haimei Wu
Headquarters
Guangzhou
Employees
146

Financial highlights

Full financials

In fiscal 2025, Baird Medical Investment generated $22.5 million in revenue, down 39.2% from fiscal 2024, its first annual decline since 2023. Baird Medical Investment reported a net loss of $27.3 million, compared with net income of $12.5 million a year earlier. Gross margin was 83.8% (down from 88.2%) and operating margin -113.7%.

Baird Medical Investment annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Revenue$22.54M$37.04M$31.46M$35.09M
Growth-39.15%+17.74%-10.35%—
Net income$-27.28M$12.45M$10.55M$12.77M
EPS (diluted)$-0.98$0.57$0.51$0.49

Analyst forecast

Forecast

Consensus

none

Avg. price target

$4.00+4359.31%

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

BDMD news

All BDMD news

Baird Medical Investment peers

Health Care sector
BDMD peer companies
CompanyPrice% ChgMarket capCompare
ICUSeaStar Medical Holding Corporation0.935-10.95%$4.97Mvs BDMD
WOKWORK Medical Technology Group LTD Class A1.10-5.13%$4.90Mvs BDMD
INBSIntelligent Bio Solutions Inc.1.39-7.95%$4.61Mvs BDMD
ICCMIceCure Medical Ltd.0.8006-19.71%$4.45Mvs BDMD
NMTCNeuroOne Medical Technologies Corporation0.6521-3.38%$5.94Mvs BDMD
CNSYCerenome Inc.0.6301-10.29%$6.16Mvs BDMD
ARAYAccuray Incorporated2.08-2.12%$6.22Mvs BDMD
SNOASonoma Pharmaceuticals Inc.0.722-10.83%$3.65Mvs BDMD

Indexes, lists and sector

Baird Medical Investment stock FAQ

What is Baird Medical Investment's stock price today?

BDMD last traded at $0.0897 as of Nov 20, 4:00 PM EST, down 12.91% on the day. Prices are delayed at least 15 minutes.

Who is Baird Medical Investment's CEO?

Ms. Haimei Wu is the chief executive officer of Baird Medical Investment Holdings Ltd, which has about 146 employees.

What is the BDMD 52-week high?

The 52-week high for BDMD is $3.70 and the 52-week low is $0.073. The stock is currently 97.6% below its high.

Compare BDMD